78 related articles for article (PubMed ID: 14702717)
1. [Early and differential cytologic diagnosis in lung cancer].
Niţu M; Măceşanu VA; Niţu M; Mărăşescu G
Pneumologia; 2003; 52(2):126-8. PubMed ID: 14702717
[No Abstract] [Full Text] [Related]
2. In search of a positive immunohistochemical marker for mesothelioma: an update.
Ordóñez NG
Adv Anat Pathol; 1998 Jan; 5(1):53-60. PubMed ID: 9868512
[No Abstract] [Full Text] [Related]
3. Pleural mesothelioma in situ and its adenocarcinoma simulator.
Bono F
Int J Surg Pathol; 2010 Dec; 18(6):519-20. PubMed ID: 21081535
[No Abstract] [Full Text] [Related]
4. Mucin-positive epithelial mesothelioma.
MacDougall DB; Wang SE; Zidar BL
Arch Pathol Lab Med; 1992 Aug; 116(8):874-80. PubMed ID: 1341882
[TBL] [Abstract][Full Text] [Related]
5. Malignant mesothelioma: cytologic diagnosis with histologic, immunohistochemical, and ultrastructural correlation.
Leong AS; Stevens MW; Mukherjee TM
Semin Diagn Pathol; 1992 May; 9(2):141-50. PubMed ID: 1609156
[TBL] [Abstract][Full Text] [Related]
6. Mucin-negative pseudomesotheliomatous adenocarcinoma of the lung: report of three cases.
Oka K; Otani S; Yoshimura T; Hashimoto T; Tobita T; Koyamatsu S; Hakozaki H; Yatabe Y
Acta Oncol; 1999; 38(8):1119-21. PubMed ID: 10665774
[No Abstract] [Full Text] [Related]
7. Pulmonary adenocarcinoma simulating malignant mesothelioma.
Tang P; Vatsia SK; Teichberg S; Kahn E
Arch Pathol Lab Med; 2001 Dec; 125(12):1598-600. PubMed ID: 11735699
[TBL] [Abstract][Full Text] [Related]
8. Mucin-positive epithelial mesothelioma and pseudomesotheliomatous adenocarcinoma.
Friedman HD; Litovsky SH; Abraham JL
Arch Pathol Lab Med; 1993 Oct; 117(10):967. PubMed ID: 8215835
[No Abstract] [Full Text] [Related]
9. The differential expression of N-cadherin and E-cadherin distinguishes pleural mesotheliomas from lung adenocarcinomas.
Peralta Soler A; Knudsen KA; Jaurand MC; Johnson KR; Wheelock MJ; Klein-Szanto AJ; Salazar H
Hum Pathol; 1995 Dec; 26(12):1363-9. PubMed ID: 8522310
[TBL] [Abstract][Full Text] [Related]
10. Calretinin, thrombomodulin, CEA, and CD15: a useful combination of immunohistochemical markers for differentiating pleural epithelial mesothelioma from peripheral pulmonary adenocarcinoma.
Comin CE; Novelli L; Boddi V; Paglierani M; Dini S
Hum Pathol; 2001 May; 32(5):529-36. PubMed ID: 11381372
[TBL] [Abstract][Full Text] [Related]
11. h-Caldesmon, a useful positive marker in the diagnosis of pleural malignant mesothelioma, epithelioid type.
Comin CE; Dini S; Novelli L; Santi R; Asirelli G; Messerini L
Am J Surg Pathol; 2006 Apr; 30(4):463-9. PubMed ID: 16625092
[TBL] [Abstract][Full Text] [Related]
12. The value of thyroid transcription factor-1 in cytologic preparations as a marker for metastatic adenocarcinoma of lung origin.
Hecht JL; Pinkus JL; Weinstein LJ; Pinkus GS
Am J Clin Pathol; 2001 Oct; 116(4):483-8. PubMed ID: 11601132
[TBL] [Abstract][Full Text] [Related]
13. Coalescent pleural malignant mesothelioma and adenocarcinoma of the lung, involving only minor asbestos exposure.
Tsuzuki T; Ninomiya H; Natori Y; Ishikawa Y
Pathol Int; 2008 Jul; 58(7):451-5. PubMed ID: 18577116
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological analysis of lung cancer resembling malignant pleural mesothelioma.
Kobashi Y; Matsushima T; Irei T
Respirology; 2005 Nov; 10(5):660-5. PubMed ID: 16268922
[TBL] [Abstract][Full Text] [Related]
15. Basal lamina reduplication in malignant epithelioid pleural mesothelioma.
Di Muzio M; Spoletini L; Strizzi L; Procopio A; Tassi G; Casalini A; Modesti A
Ultrastruct Pathol; 1998; 22(6):467-75. PubMed ID: 9891926
[TBL] [Abstract][Full Text] [Related]
16. Localized mesothelioma tumour arising synchronously with a primary contralateral lung cancer.
Andrews W; Paul S; Narula N; Altorki NK
Interact Cardiovasc Thorac Surg; 2013 Dec; 17(6):1061-2. PubMed ID: 23956266
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of membranous staining of mesothelioma.
King JA; Tucker JA
Cell Vis; 1998; 5(1):24-7. PubMed ID: 9660721
[TBL] [Abstract][Full Text] [Related]
18. Coexistent atypical adenomatous hyperplasia, primary lung adenocarcinoma and pleural mesothelioma in an asbestos-exposed subject.
Thomas DH; Attanoos RL; Gibbs AR
Histopathology; 2004 Nov; 45(5):540-2. PubMed ID: 15500660
[No Abstract] [Full Text] [Related]
19. Value of calretinin immunostaining in differentiating epithelial mesothelioma from lung adenocarcinoma.
Ordóñez NG
Mod Pathol; 1998 Oct; 11(10):929-33. PubMed ID: 9796717
[TBL] [Abstract][Full Text] [Related]
20. The value of ThinPrep and cytospin preparation in pleural effusion cytological diagnosis of mesothelioma and adenocarcinoma.
Ylagan LR; Zhai J
Diagn Cytopathol; 2005 Mar; 32(3):137-44. PubMed ID: 15690333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
